Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Pseudomonas Aeruginosa: early-phase trial registry
3 of 5 indexed Pseudomonas Aeruginosa trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Pseudomonas Aeruginosa: 5 US clinical trials tracked, 3 recruiting.
Pseudomonas Aeruginosa is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Zafer Soultan, running 1 of these trials.
Enrollment posture brief
Registry condition pseudomonas-aeruginosa
OPEN 3 | RECR 60% | LATE 0 | EARLY 3 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)
Pseudomonas Aeruginosa lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Pseudomonas Aeruginosa on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Pseudomonas Aeruginosa is recruiting above its size-band peers.
3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Pseudomonas Aeruginosa research.
Zafer Soultan accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Pseudomonas Aeruginosa enrolment sits around 100 participants.
Median target enrolment is 100 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.
-
Pseudomonas Aeruginosa splits between interventional and observational designs.
3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
PMT for MDRO Decolonization
University of Pennsylvania
NCT05632315
Pathobiomes in Gut of Critically Ill Patients
University of Chicago
NCT06822465
A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection
Respirion Pharmaceuticals Pty
NCT06016088
Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection
Gilead Sciences
NCT01055847
The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic Fibrosis
Zafer Soultan
NCT01616862
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Pseudomonas Aeruginosa records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Pseudomonas Aeruginosa trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Pseudomonas Aeruginosa page
5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Pseudomonas Aeruginosa trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Zafer Soultan sponsors the most Pseudomonas Aeruginosa trials on record, review their full trial history before evaluating a specific study. See Zafer Soultan's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pseudomonas Aeruginosa condition card totals 5 registered trials; most-linked intervention Aztreonam for Inhalation (AI); top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.